Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3

Ethan V. Abel, Kevin J. Basile, Curtis H. Kugel, Agnieszka K. Witkiewicz, Kaitlyn Le, Ravi K. Amaravadi, Giorgos C. Karakousis, Xiaowei Xu, Wei Xu, Lynn M. Schuchter, Jason B. Lee, Adam Ertel, Paolo Fortina, Andrew E. Aplin

Research output: Contribution to journalArticlepeer-review

188 Scopus citations

Fingerprint

Dive into the research topics of 'Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3'. Together they form a unique fingerprint.

Medicine & Life Sciences